1. Soflaee, M.H., R. Kesavan, U. Sahu, A. Tasdogan and E. Villa, et al., 2022. Purine nucleotide depletion prompts cell migration by stimulating the serine synthesis pathway. Nat. Commun., Vol. 13. 10.1038/s41467-022-30362-z.
   CrossRef  |  Direct Link  |  
2. Ali, E.S., A. Lipońska, B.P. O’Hara, D.R. Amici and M.D. Torno, 2022. The mTORC1-SLC4A7 axis stimulates bicarbonate import to enhance de novo nucleotide synthesis. Mol. Cell, 82: 3284-3298.
   CrossRef  |  Direct Link  |  
3. Villa, E., U. Sahu, B.P. O’Hara, E.S. Ali and K.A. Helmin et al., 2021. mTORC1 stimulates cell growth through SAM synthesis and m⁶A mRNA-dependent control of protein synthesis. Mol. Cell, 10.1016/j.molcel.2021.03.009.
   CrossRef  |  Direct Link  |  
4. Shireman, J.M., F. Atashi, G. Lee, E.S. Ali and M.R. Saathoff et al., 2021. De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma. Brain, 144: 1230-1246.
   CrossRef  |  Direct Link  |  
5. Ali, E.S., U. Sahu, E. Villa, B.P. O’Hara and P. Gao et al., 2020. ERK2 phosphorylates PFAS to mediate posttranslational control of de novo purine synthesis. Mol. Cell, 78: 1178-1191.e6.
   CrossRef  |  Direct Link  |  
6. Ali, E.S., G.Y. Rychkov and G.J. Barritt, 2020. Targeting Ca²⁺ signaling in the initiation, promotion and progression of hepatocellular carcinoma. Cancers, 10.3390/cancers12102755.
   CrossRef  |  Direct Link  |  
7. Villa, E., E. Ali, U. Sahu and I. Ben-Sahra, 2019. Cancer cells tune the signaling pathways to empower de novo synthesis of nucleotides. Cancers, 10.3390/cancers11050688.
   CrossRef  |  Direct Link  |  
8. Saathoff, M., J. Shireman, E. Ali, C. Park, I. Ben-Sahra and A. Ahmed, 2019. DRES-09. regulatory effects of the ciliary gtpase ARL13B on purine metabolism in GBM. Neuro-Oncol., Vol. 21. 10.1093/neuonc/noz175.297.
   CrossRef  |  Direct Link  |  
9. Ali, E.S., G.Y. Rychkov and G.J. Barritt, 2019. Deranged hepatocyte intracellular Ca²⁺ homeostasis and the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma. Cell Calcium, Vol. 82. 10.1016/j.ceca.2019.102057.
   CrossRef  |  Direct Link  |  
10. Ali, E.S. and N. Petrovsky, 2019. Calcium signaling as a therapeutic target for liver steatosis. Trends Endocrinol. Metab., 30: 270-281.
    CrossRef  |  Direct Link  |  
11. Ahmed, A.U., J. Shireman, F. Atashi, M. Saathoff and E. Ali et al., 2019. OS6.1 targeting purine metabolism to overcome therapeutic resistance in glioblastoma. Neuro-Oncol., Vol. 21. 10.1093/neuonc/noz126.039.
    CrossRef  |  Direct Link  |  
12. Tam, K.C., E. Ali, J. Hua, T. Chataway and G.J. Barritt, 2018. Evidence for the interaction of peroxiredoxin-4 with the store-operated calcium channel activator STIM1 in liver cells. Cell Calcium, 74: 14-28.
    CrossRef  |  Direct Link  |  
13. Paz, M.F.C.J., M.V.O.B.D. Alencar, A.L.G. Junior, K.D.C. Machado and M.T. Islam et al., 2018. Correlations between risk factors for breast cancer and genetic instability in cancer patients-a clinical perspective study. Front. Genet., Vol. 8. 10.3389/fgene.2017.00236.
    CrossRef  |  Direct Link  |  
14. Paz, M.F.C.J., A.L. Gomes Jr., M.V.O.B. de Alencar, S. Tabrez and M.T. Islam et al., 2018. Effect of diets, familial history and alternative therapies on genomic instability of breast cancer patients. Applied Biochem. Biotechnol., (In Press). 10.1007/s12010-018-2918-9.
    CrossRef  |  Direct Link  |  
15. Paz, M.F.C.J., A.L. Gomes, M.T. Islam, S. Tabrez and N.R. Jabir et al., 2017. Assessment of chemotherapy on various biochemical markers in breast cancer patients. J. Cell. Biochem., 119: 2923-2928.
    CrossRef  |  Direct Link  |  
16. Ali, E.S., G.Y. Rychkov and G.J. Barritt, 2017. Metabolic disorders and cancer: hepatocyte store-operated Ca²⁺ channels in nonalcoholic fatty liver disease. Adv. Exp. Med. Biol., 993: 595-621.
    CrossRef  |  Direct Link  |  
17. Ali, E.S., J. Hua, C.H. Wilson, G.A. Tallis, F.H. Zhou, G.Y. Rychkov and G.J. Barritt, 2016. The glucagon-like peptide-1 analogue exendin-4 reverses impaired intracellular Ca²⁺ signalling in steatotic hepatocytes. Biochim. Biophys. Acta., 1863: 2135-2146.
    CrossRef  |  Direct Link  |  
18. Ali, E.S., H. Rajapaksha, J.M. Carr and N. Petrovsky, 2016. Norovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens. Antiviral Res., 133: 14-22.
    CrossRef  |  Direct Link  |  
19. Wilson, C.H., E.S Ali, N. Scrimgeour, A.M Martin and J. Hua et al., 2015. Steatosis inhibits liver cell store-operated Ca²⁺ entry and reduces ER Ca²⁺ through a protein kinase c-dependent mechanism. Biochem. J., 466: 379-390.
    CrossRef  |  Direct Link  |  
20. Lundborg, M., E. Ali and G. Widmalm, 2013. An in silico virtual screening study for the design of norovirus inhibitors: fragment-based molecular docking and binding free energy calculations. Carbohydr. Res., 378: 133-138.
    CrossRef  |  Direct Link  |  
21. Chervona, Y., M.N. Hall, A. Arita, F. Wu and H. Sun et al., 2012. Associations between arsenic exposure and global posttranslational histone modifications among adults in Bangladesh. Cancer Epidemiol. Biomarkers Prev., 21: 2252-2260.
    CrossRef  |  Direct Link  |